Serial 88109969
Live / Registered — Registered (as of 29 Sept 2020)
What this means for you
Registered since 29 Sept 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 02 Oct 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 88109969
- Registration number
- 6164693
- Mark type
- Design / logo
- Filed
- 09 Sept 2018
- Published for opposition
- 06 Nov 2018
- Registered
- 29 Sept 2020
- Next maintenance filing
- §8 declaration of use, filed 02 Oct 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Analgesics, antiphlogistics and antirheumatics
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 02 Oct 2026 — TEAS SECTION 8 & 15 RECEIVED
- 29 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jul 2020 — USE AMENDMENT FILED
- 04 Aug 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 30 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2020 — SOU EXTENSION 3 GRANTED
- 27 Jun 2020 — SOU EXTENSION 3 FILED
- 27 Jun 2020 — SOU TEAS EXTENSION RECEIVED
- 02 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2019 — SOU EXTENSION 2 GRANTED